| Literature DB >> 21320356 |
Nikolaos Kontarakis1, Ioanna G Tsiligianni, Polyvios Papadokostakis, Evangelia Giannopoulou, Loukas Tsironis, Vasilios Moustakis.
Abstract
BACKGROUND: Antibiotic over-prescribing has generally been considered to be common in Greece, however not much is known about current antibiotic use.Entities:
Year: 2011 PMID: 21320356 PMCID: PMC3042939 DOI: 10.1186/1756-0500-4-38
Source DB: PubMed Journal: BMC Res Notes ISSN: 1756-0500
Most common diagnoses in adults and children in the study
| Infection | Episodes | % | |
|---|---|---|---|
| Children | Respiratory | 72 | 82.8 |
| Skin-soft tissues | 7 | 8 | |
| Tooth abscess | 5 | 5.7 | |
| Gastrointestinal | 2 | 2.3 | |
| Others | 1 | 1.1 | |
| Adults | Respiratory | 100 | 71.4 |
| Skin-soft tissues | 16 | 11.4 | |
| Urinary | 12 | 8.6 | |
| Tooth abscess | 8 | 5.7 | |
| Genital | 4 | 2.9 | |
Prescribed antibiotics as DDD and DID, and percentages
| Effective Substance | Frequency | DDD | DID | % DDD |
|---|---|---|---|---|
| Penicillins J01C | ||||
| • Phenoxymethyl-penicillin J01CE02 | 1 | 6 | 0.17 | 0.8 |
| • Amoxicillin J01CA04 | 5 | 42 | 1.16 | 5.3 |
| • Amoxicillin-clavulanate J01CR02 | 28 | 346 | 9.57 | 43.4 |
| Cephalosporins J01DA | 24 | 154 | 4.26 | 19.3 |
| Macrolides J01F | 24 | 216 | 5.98 | 27.1 |
| Sulphonamides QJ01EQ | 1 | 14.4 | 0.4 | 1.8 |
| Antifungals D01 | 2 | 10.5 | 0.29 | 1.3 |
| Antiviral J05A | 1 | 2.5 | 0.07 | 0.3 |
| Antiprotozoal-anthelminthics (P01-P02) | 1 | 6 | 0.17 | 0.8 |
| Penicillins J01C | ||||
| • Phenoxymethyl-penicillin J01CE02 | 2 | 12 | 0.21 | 0.9 |
| • Amoxicillin J01CA04 | 12 | 162 | 2.79 | 11.5 |
| • Amoxicilline-clavunalate J01CR02 | 16 | 272 | 4.68 | 19.3 |
| Cephalosporins J01DA | 43 | 418 | 7.2 | 29.7 |
| Macrolides J01F | 50 | 389 | 6.7 | 27.7 |
| Quinolones J01M | 5 | 55 | 0.95 | 3.9 |
| Imidazoles J01XD | 2 | 15 | 0.26 | 1.1 |
| Sulphonamides QJ01EQ | 3 | 30 | 0.52 | 2.1 |
| Lincozamides J01F | 2 | 8 | 0.14 | 0.6 |
| Antifungals D01 | 5 | 46 | 0.79 | 3.3 |
DDD = daily defined doses of antibiotics, DID = daily defined doses of antibiotics for 1000 people/day.
DDDs, DIDs and percentages of DDD of antibiotics according to infection
| Infection | Antimicrobial agents | % children | % adults | DDD children (%) | DDD adults (%) | DID children | DID adults |
|---|---|---|---|---|---|---|---|
| Penicillins J01C | 37.5% | 22% | 344 (48.9%) | 337.5 (33%) | 9.53 | 9.67 | |
| Cephalosporins J01DA | 29.2% | 30% | 142 (20.1%) | 306 (30%) | 3.92 | 5.27 | |
| Macrolides, lincozamides J01F | 31.9% | 48% | 204 (29%) | 378 (37%) | 5.65 | 6.51 | |
| Sulphonamides J01E | 1.4% | 0 | 14.4 (2%) | 0 | 0.4 | 0 | |
| Penicillins J01C | 8.3% | 24 (18%) | 0.41 | ||||
| Cephalosporins J01DA | 25% | 24 (18%) | 0.41 | ||||
| Quinolones J01M | 41.7% | 55 (41.4%) | 0.95 | ||||
| Sulphonamides J01 | 25% | 30 (22.6%) | 0.52 | ||||
| Penicillins J01C | 42.8% | 6.3% | 15.4 (52.4%) | 12 (8.3%) | 0.58 | 0.21 | |
| Cephalosporins J01DA | 28.6% | 62.5% | 6.5 (19.5%) | 88 (60%) | 0.18 | 1.52 | |
| Macrolides, lincozamides J01F | 12.5% | 11 (7.5%) | 0.19 | ||||
| Other | 28.6% | 18.7% | 7.5 (25.5%) | 35.5 (24.2%) | 0.21 | 1.09 | |
| Other | 100% | 25.5 (100%) | 0.57 | ||||
| Macrolides, lincozamides J01F | 50% | 12 (66.7%) | 0.33 | ||||
| Other | 50% | 6 (33.3%) | 0.17 | ||||
| Penicillins J01C | 80% | 75% | 30 (83.3%) | 72 (90%) | 0.83 | 1.86 | |
| Cephalosporins J01DA | 20% | 6 (16.7%) | 0.17 | ||||
| Macrolides, lincozamides J01F | 25% | 8.0 (10%) | 0.14 | ||||
| Other | 100% | 2.5 (100%) | 0.07 |